Benefits of Frankincense: What the Research Shows About This Ancient Anti-Inflammatory Herb

Frankincense has been valued for thousands of years — burned in religious ceremonies, traded across ancient spice routes, and used in traditional medicine across Africa, the Middle East, and Asia. Today, it's drawing serious scientific attention, particularly for its potential role in supporting inflammation response, joint health, and immune function. Here's what research generally shows, and what shapes how different people respond to it.

What Is Frankincense?

Frankincense comes from the resin of Boswellia trees — most commonly Boswellia serrata and Boswellia sacra. The resin can be burned as incense, used in essential oil form, or processed into oral supplements. When people talk about the health-related benefits of frankincense, they're almost always referring to Boswellia extract, which is standardized to contain active compounds called boswellic acids.

Boswellic acids — particularly AKBA (acetyl-11-keto-β-boswellic acid) — are considered the primary bioactive components. Research suggests these compounds may inhibit a specific enzyme called 5-lipoxygenase (5-LOX), which plays a role in the body's production of leukotrienes — molecules involved in inflammatory signaling.

What the Research Generally Shows 🔬

Inflammation and Joint Health

The most studied application for Boswellia extract involves osteoarthritis and joint inflammation. Several clinical trials — including randomized controlled studies — have found that Boswellia supplementation may help reduce joint pain, stiffness, and swelling, particularly in the knees. A number of these studies showed symptom improvements within 4–8 weeks of supplementation.

The quality of this evidence varies. Some trials are small and short-term. Others are well-designed and peer-reviewed. The general consensus in the research community is that the evidence for Boswellia in osteoarthritis is among the more credible areas of herbal supplement research — but it's still considered promising rather than conclusive by most regulatory and clinical standards.

Gut and Digestive Inflammation

Some research has examined Boswellia's potential role in inflammatory bowel conditions, including Crohn's disease and ulcerative colitis. A few clinical trials have shown comparable outcomes to some standard treatments in specific populations, though the research base here is smaller and less consistent. These findings are considered emerging, and the mechanisms aren't fully established.

Respiratory Support

Traditional use of frankincense for respiratory health has some scientific backing. Early research suggests boswellic acids may influence airway inflammation pathways. Small clinical studies have examined its role in asthma management with mixed but cautiously positive results. This area needs significantly more research before strong conclusions can be drawn.

Brain and Cognitive Function

Animal studies and some early human research have explored whether frankincense compounds may support neurological health — potentially through anti-inflammatory and antioxidant mechanisms. This research is at an early stage, and results from animal models don't automatically translate to humans.

Key Variables That Shape Individual Outcomes

Not everyone who takes Boswellia extract experiences the same results. Several factors influence how the body processes and responds to it:

How Different Health Profiles Experience Different Results 🌿

Someone with mild, age-related joint discomfort and no underlying conditions may notice meaningful effects from a standardized Boswellia supplement. Someone managing a diagnosed autoimmune or inflammatory disease — particularly one already treated with medication — faces a much more complex picture. The interaction between Boswellia's 5-LOX inhibition and existing drug therapies isn't fully mapped, and assuming the two will work synergistically (or even safely together) without medical input isn't well-supported by current evidence.

People using frankincense as essential oil for aromatherapy are working with a different set of compounds entirely. Inhaled or topically applied frankincense doesn't deliver boswellic acids in the same way that oral supplementation does — so the research on Boswellia extract doesn't directly apply to aromatherapy use.

There are also populations for whom the research picture is particularly thin: pregnant and breastfeeding individuals, children, and people with liver or kidney conditions have not been well-studied in Boswellia trials.

What Remains Unclear

Research on frankincense is active but still maturing. Most clinical trials are short-duration and involve relatively small sample sizes. Long-term safety data for oral Boswellia supplementation is limited. The optimal dose, form, and duration of use haven't been definitively established across populations.

What's well-established is the mechanism: boswellic acids appear to act on specific inflammatory pathways in ways that conventional ibuprofen-class drugs do not — which is why researchers find them scientifically interesting. What isn't yet established is how reliably that translates into meaningful outcomes for a given individual, and under what conditions.

How that applies to any specific person depends heavily on their baseline inflammation levels, overall diet, existing conditions, and what else they're taking — details the research alone can't answer.